VANCOUVER, BRITISH COLUMBIA--(Marketwired - Feb 6, 2015) - Response Biomedical Corp. ("Response" or the "Company") (RBM.TO)(RPBIF) today announced that it has expanded the scope of its agreement to ...

BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced updated data from Part A of the ...